Browse the complete list of publications for studies listed on CDAS.
Filter results of publications table below
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States. | 40069139 | Vogtmann E, Yano Y, Zouiouich S, Hua X, Wan Y, Purandare V, Li S, Dagnall CL, Jones K, Hicks BD, Hutchinson A, Caporaso JG, Wheeler W, Huang WY, Freedman ND, Sandler DP, Beane Freeman LE, Liao LM, Gail MH, Shi J, Abnet CC, Sinha R | Cancer | 2025 | PLCO |
| Predictive performance of risk prediction models for lung cancer incidence in Western and Asian countries: a systematic review and meta-analysis. | 40038330 | Juang YR, Ang L, Seow WJ | Sci Rep | 2025 | PLCO |
| Assessing Lung Cancer Screening Eligibility of Patients With Lung Cancer in the Boston Lung Cancer Study: An Analysis of 7186 Lung Cancer Cases. | 39864777 | Potter AL, Guo Q, Srinivasan D, Yang ME, McCarthy M, Wang D, Kothari J, Shafer A, Christiani DC, Jeffrey Yang CF | Ann Thorac Surg | 2025 | PLCO |
| Data augmented lung cancer prediction framework using the nested case control NLST cohort. | 40071099 | Jiang Y, Manem VSK | Front Oncol | 2025 | NLST |
| Visual Emphysema as a Category Modifier in Lung-RADS: Secondary Analysis of National Lung Screening Trial. | 40049568 | Jang S, Kim J, Lee S, Kim YW, Kim J, Lee KW, Lee CT | J Am Coll Radiol | 2025 | NLST |
| Positive Screens Are More Likely in a National Lung Cancer Screening Registry Than the National Lung Screening Trial. | 40023436 | Tailor TD, Gutman R, An N, Hoffman RM, Chiles C, Carlos RC, Sicks JD, Gareen IF | J Am Coll Radiol | 2025 | NLST |
| Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery. | 39187984 | Downs TM, Bailey HH, Lozar T, Schmitz NS, Green H, Scarlett CO, Havighurst TC, Twaroski K, DeShong K, Wollmer B, Bivalacqua TJ, Saltzstein DR, Shore N, Kim K, Huang W, Ricke WA, Barroilhet L, House M, Parnes HL, Messing E | Cancer Prev Res (Phila) | 2025 | |
| Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification. | 40305105 | Hubbard AK, Brown DW, Liu J, Chan IC, Zhou W, Genovese G, DePaulis A, Srinivasan S, Lin SH, Blechter B, Buller ID, Zeng Q, Cao Y, Huang WY, Freedman ND, Zhang H, Dutta D, Chanock SJ, Bolton KL, Machiela MJ | Cancer Res | 2025 | PLCO |
| Dietary Fatty Acids and Bladder Cancer Risk: Insights from the PLCO Cancer Screening Trial. | 40237627 | Li G, Zheng W, Zhang X, Chen Y | Nutr Cancer | 2025 | PLCO |
| Comorbidity in Midlife and Cancer Outcomes. | 40193077 | Lavery JA, Boutros PC, Moskowitz CS, Jones LW | JAMA Netw Open | 2025 | PLCO |
| AutoCOPD-A novel and practical machine learning model for COPD detection using whole-lung inspiratory quantitative CT measurements: a retrospective, multicenter study. | 40242563 | Lin F, Zhang Z, Wang J, Liang C, Xu J, Zeng X, Zeng Q, Chen H, Zhuang J, Ma Y, Ma Q, Shi R, Xu J, Li Y, Yuan L, Wei X, Wu L, Huang R, Xiao T, Liang W, Zheng J, He J, Liu Y, Liang Z, Zhong N, Lu W | EClinicalMedicine | 2025 | NLST |
| Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease. | 40236262 | Behr CM, IJzerman MJ, Kip MMA, Groen HJM, Heuvelmans MA, van den Berge M, van der Harst P, Vonder M, Vliegenthart R, Koffijberg H | JTO Clin Res Rep | 2025 | NLST |
| Virtual lung screening trial (VLST): An in silico study inspired by the national lung screening trial for lung cancer detection. | 40209556 | Tushar FI, Vancoillie L, McCabe C, Kavuri A, Dahal L, Harrawood B, Fryling M, Zarei M, Sotoudeh-Paima S, Ho FC, Ghosh D, Harowicz MR, Tailor TD, Luo S, Segars WP, Abadi E, Lafata KJ, Lo JY, Samei E | Med Image Anal | 2025 | NLST |
| Quantitative CT Measures of Lung Fibrosis and Outcomes in the National Lung Screening Trial. | 40208581 | Wang JM, Bose S, Murray S, Labaki WW, Kazerooni EA, Chung JH, Flaherty KR, Han MK, Hatt CR, Oldham JM | Ann Am Thorac Soc | 2025 | NLST |
| Respiratory Function as a Prognostic Factor for Lung Cancer in Screening and General Populations. | 39589279 | Murison KR, Warkentin MT, Khodayari Moez E, Brhane Y, Liu G, Hung RJ | Ann Am Thorac Soc | 2025 | NLST |
| Methods matter for dietary supplement exposure assessment: comparing prevalence, product types, and amounts of nutrients from dietary supplements in the Interactive Diet and Activity Tracking in the American Association of Retired Persons cohort stu… | 40185234 | Cowan-Pyle AE, Bailey RL, Gahche JJ, Dwyer JT, Reynolds LM, Carroll RJ, Mallick BK, Mitchell DC, Tooze JA | Am J Clin Nutr | 2025 | IDATA |
| Increased Severity of Prostate Cancer Presentation in an Appalachian Cohort Compared to National Data | Marvin A. Simpkins, Garrett Douglas, Emily Yablonsky, Lawrence Wyner, Justyn Blankenship | Clinical Genitourinary Cancer | 2025 | PLCO | |
| Epigenetic assessments of alcohol consumption predict mortality in smokers at risk for lung cancer in the prostate, lung, colorectal and ovarian cancer screening trial. | 40402951 | Philibert R , Beach SRH , Mills JA , Dawes K , Hoffman RM , Sieren JC , Froehlich EM , deBlois KM , Long JD | PLoS One | 2025 | PLCO |
| Adherence to the EAT-Lancet diet reduces the risk of renal cancer: Results from a population-based prospective study. | 40383051 | Wei Q, Yang M, Zhu Z, Xiang L, Wang Y, Peng L, Tang Y, Deng S, Gu H | Public Health | 2025 | PLCO |
| Assessing the risk of second primary lung cancer in women after previous breast cancer. | 40374891 | Huang Y, Lin JJ, Wisnivesky JP, Kong CY, Sigel K | BJC Rep | 2025 | PLCO |